Elsevier

Neuroscience Letters

Volume 107, Issues 1–3, 15 December 1989, Pages 211-215
Neuroscience Letters

Reduced GABA uptake sites in the temporal lobe in schizophrenia

https://doi.org/10.1016/0304-3940(89)90819-7Get rights and content

Abstract

The binding of [3H]nipecotic acid, a ligand for labelling GABA uptake sites in brain, was measured in left and right frontal cortex, polar temporal cortex, hippocampus and amygdala from control and schizophrenic postmortem brains. In schizophrenic brains, single concentration [3H]nipecotic acid binding was reduced bilaterally in amygdala and hippocampus and on the left side only in polar temporal cortex. These data suggest that GABA neurones are involved in the cerebral atrophy of schizophrenia and, in agreement with other studies, that this process is most pronounced in left temporal cortex.

References (20)

  • A.J. Cross et al.

    Gamma-aminobutyric acid in the brain in schizophrenia

    Lancet.

    (1979)
  • T.L. Perry et al.

    γ-Aminobutyric acid deficiency in brain of schizophrenic patients

    Lancet

    (1979)
  • E.G.S. Spokes et al.

    Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects

    J. Neurol. Sci.

    (1980)
  • B. Bogerts et al.

    Basal ganglia and limbic system pathology in schizophrenia

    Arch. Gen. Psychiatr.

    (1985)
  • R. Brown et al.

    Post-mortem evidence of structural brain changes in schizophrenia

    Differences in brain weight, temporal horn area and parahippocampal gyrus compared with affective disorder

    Arch. Gen. Psychiatr.

    (1986)
  • J.F.W. Deakin et al.

    Changes in [3H]d-aspartate and [3H]kainate binding in schizophrenic post mortem brains

    J. Neurochem.

    (1989)
  • P. Falkai et al.

    Cell loss in the hippocampus of schizophrenics

    Eur. Arch. Psychiatr. Neurol. Sci.

    (1986)
  • I.N. Ferrier et al.

    Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

    Life Sci.

    (1983)
  • L.-M. Gunne et al.

    Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis

    Nature (Lond.)

    (1984)
  • J.O. Hang

    Pneumoencephalographic studies in mental disease

    Acta Psychiatr. Scand.

    (1962)
There are more references available in the full text version of this article.

Cited by (175)

  • Schizophrenia and neurogenesis: A stem cell approach

    2017, Neuroscience and Biobehavioral Reviews
    Citation Excerpt :

    Substantial evidence indicates that cortical GABA neurotransmission is altered in SCZ (Lewis, 2011). Early post-mortem studies of SCZ revealed evidence of decreased GABA synthesis (Bird et al., 1978) and uptake (Simpson et al., 1989), and increased GABAA receptors binding in the neocortex (Hanada et al., 1987). More recently, studies conducted by a number of research groups, using different techniques and cohort subjects, have consistently found reduced levels of the GABA-synthesizing enzyme GAD67 mRNA and protein levels in the dorsolateral prefrontal cortex (Guidotti et al., 2000; Vawter et al., 2002; Straub et al., 2007; Mellios et al., 2009; Duncan et al., 2010), orbitofrontal, superior temporal, anterior cingulate, primary motor and visual cortex (Impagnatiello et al., 1998; Woo et al., 2004; Hashimoto et al., 2008; Thompson et al., 2009), increased GAD25/GAD67 and NKCC1/KCC2 ratios (Hyde et al., 2011), decreases in the GABA transporter, GAT1 (Ohnuma et al., 1999; Hashimoto et al., 2008), and alterations in the expression of different GABAA receptor subunits, including decrease in mRNA for α1, α5, β2, δ, and θ subunits and increase in α2 and ρ2, subunits (Lewis et al., 2005; Hashimoto et al., 2008; Beneyto et al., 2011; Fatemi et al., 2013).

View all citing articles on Scopus

This work was supported by the North West Regional Health Authority and the Wellcome Trust.

View full text